Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types i and II

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 10, 2012, Pages 1262-1269

  Ha, Andrew H ^a   Tarnopolsky, Mark A ^a   Bergstra, T Graham ^a   Nair, Girish M ^b   Al Qubbany, Atif ^a   Healey, Jeff S ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

atrio ventricular block; myotonic dystrophy; pacemaker; sudden death

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR MORTALITY; DEFIBRILLATOR; ECG ABNORMALITY; FAMILY HISTORY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTENSION; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; PROGNOSIS; SUDDEN DEATH; TRINUCLEOTIDE REPEAT;

ADULT; AGE FACTORS; ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; COHORT STUDIES; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOTONIC DISORDERS; MYOTONIC DYSTROPHY; PACEMAKER, ARTIFICIAL; PREVALENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84867103854     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03351.x     Document Type: Article

References (21)

1. Ranum LP, Day JW,. Myotonic dystrophy clinical and molecular parallels between myotonic dystrophy type 1 and 2. Curr Neurol Neurosci Rep 2002; 2: 465-470.
2. Carson NL,. Analysis of repetitive regions in myotonic dystrophy type 1 and 2. Curr Protoc Hum Genet 2009; 61:9.6.1-9.6.19
3. Mastroyiannopoulos NP, Shammas C, Phylactou LA,. Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy. Biol Cell 2010; 102: 515-523.
4. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, et al,. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008; 358: 2688-2697.
5. Mathieu J, Allard P, Potvin L, Prevost C, Begin P,. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999; 52: 1658-1662.
6. Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, Lanforet P, et al,. Relationship among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation 1999; 99: 1041-1046.
7. de Die-Smulders CEM, Howeler CJ, Thijs C, Mirandolle JF, Anten HB, Smeets HJM, Chandler KE, et al,. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998; 121: 1557-1563.
8. Dello Russo A, Pace M, Bellocci F,. Sudden death in myotonic dystrophy. N Engl J Med 2008; 359: 1626.
9. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D,. Long-term follow-up of arrhyythmias in patients with myotonic dystrophy treated by pacing: A multi-centre diagnostic pacemaker study. J Am Coll Cardiol 2002; 40: 1645-1652.
10. Hermans MCE, Pinto YM,. Sudden death in myotonic dystrophy. N Engl J Med 2010; 359: 1626-1629.
11. Epstein AE, DiMarco JP, Ellenbogen KA, Estes MNA, Freedman RA, Leonard GS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidlines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhy mia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408.
12. Breton R, Matthieu J,. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009; 25: e23-e27.
13. Hinkle LE Jr, Thaler HT,. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-464.
14. Clarke NRA, Kellion AD, Nixon J, Hilton-Jones D, Forfar JC,. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy. Heart 2001; 86: 411-416.
15. Melacini P, Villanova C, Menegazzo E, Novelli, G, Danieli G, Rizzoli G, Fasoli G, et al,. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995; 25: 239-245.
16. Nazarian S, Wagner KR, Caffo BS, Tomaselli GF,. Clinical predictors of conduction disease progression in Type I myotonic muscular dystrophy. Pacing Clin Electrophysiol 2010; 34: 171-176.
17. Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W,. Cardiac involvement in CTG expansion in myotonic dystrophy. J Neurol 2002; 249: 693-698.
18. Koshelev M, Sarma S, Price RE, Wehrens XHT, Cooper TA,. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum Mol Genet 2010; 19: 1066-1075.
19. Ohm O-J, Breivik K,. Patients with high-grade atrioventricular block treated and not treated with a pacemakerr. Acta Med Scand 1978; 203: 521-528.
20. Toff WD, Camm AJ, Skehan JD,. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005; 353: 145-155.
21. Connolly SJ, Kerr CR, Gent M, Roberts RS, Tech RM, Yusuf S, Gillis AM, et al,. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342: 1385-1391.